TrianglePUBLICATIONS · 33417474
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Mar 10
- First author
- Kadauke S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kadauke S
- type
- Author
- name
- Myers RM
- type
- Author
- name
- Li Y
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Baniewicz D
- type
- Author
- name
- Barrett DM
- type
- Author
- name
- Barz Leahy A
- type
- Author
- name
- Callahan C
- type
- Author
- name
- Dolan JG
- type
- Author
- name
- Fitzgerald JC
- type
- Author
- name
- Gladney W
- type
- Author
- name
- Lacey SF
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kadauke S
- type
- Author
- name
- Myers RM
- type
- Author
- name
- Li Y
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Baniewicz D
- type
- Author
- name
- Barrett DM
- type
- Author
- name
- Barz Leahy A
- type
- Author
- name
- Callahan C
- type
- Author
- name
- Dolan JG
- type
- Author
- name
- Fitzgerald JC
- type
- Author
- name
- Gladney W
- type
- Author
- name
- Lacey SF
- type
- Author
- bibliography ids
- nci-bib-41aa74a1e0d0fe4a6d54a522
- book metadata
- content sha256
- 71056f13ef7e2d7890aecd9b39b8f3ea4038b18dfe99665210a095d21812e1be
- document type
- citation
- dois
- 10.1200/JCO.20.02477
- electronic publication date
- display
- 2021 Jan 8
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33417474
- immutable id
- pubmed:33417474@71056f13ef7e2d7890aecd9b39b8f3ea4038b18dfe99665210a095d21812e1be
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 8
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 920-930
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 33417474
- provenance
- batch id
- 9bca82d1bba2b27adc79
- provider
- NCBI PubMed ESummary
- record sha256
- d5679bb7ade6d524690985e7ce1311f22d7a60e3e51d20651ca42701c7a6f7e9
- response sha256
- c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
- retrieved at
- 2026-09-09T23:47:56.131551+00:00
- publication date
- display
- 2021 Mar 10
- precision
- day
- year
- 2021
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.
Preserved source evidence · Not medical advice